Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

NCT06133062 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma Non-resectable

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab
RADIATION: Proton radiotherapy

Sponsor

Chang Gung Memorial Hospital